Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM159PT
TNBC
Basal B
Trametinib
MEK
MAPK
9042.05
uM
inf
0.00489
0.5173 0.4903 0.2989 0.3056
0.8755
3.1161
HCC1187
TNBC
Basal A
LY294002
PI3K
PI3K
7812.029
uM
inf
inf
1.0500 1.0500 0.0000 -0.0475
-56.7271
0.9642
SUM159PT
TNBC
Basal B
Trametinib
MEK
MAPK
7920.05
uM
inf
0.02034
0.4715 0.5077 0.6584 0.2518
0.9823
4.1624
MCF 10A
NM
Basal B
Ribavirin
15392.211
uM
inf
1000.00000
0.6244 0.0123 0.2385 0.1289
0.6395
2.9667
MDA-MB-175-VII
HR+
Luminal
PS-1145
IKK
NFKB
7500.065
uM
inf
inf
0.5879 0.5879 0.0000 0.1172
0.4159
0.8201
HCC1187
TNBC
Basal A
Methotrexate
DHFR
Metabolism
7432.084
uM
inf
0.04650
0.7826 0.8570 4.9898 0.0847
0.6431
0.8538
BT-20
TNBC
Basal A
Ribavirin
15385.211
uM
inf
inf
0.4315 0.4315 0.0000 0.1628
0.4682
0.7321
HCC1143
TNBC
Basal A
MG-132
Proteasome
Proteasome
14203.189
uM
inf
inf
0.2602 0.2602 0.0000 0.4744
0.4731
1.6955
MDA-MB-175-VII
HR+
Luminal
SB-3CT
MMP2/9
MMP
10818.144
uM
inf
inf
0.8824 0.8824 0.0000 0.1129
0.2209
0.4912
MDA-MB-157
TNBC
Basal B
SB-3CT
MMP2/9
MMP
12594.168
uM
inf
22.51110
0.8515 0.8506 2.5343 0.0205
0.7536
1.2703
LY2
HR+
Luminal
AG1024
IGF1R
RTK
7477.066
uM
inf
inf
0.2846 0.2846 0.0000 0.3601
0.3237
0.3409
HCC2185
TNBC
Luminal
JNK-IN-5A
JNK
JNK
10996.144
uM
inf
inf
0.3659 0.3659 0.0000 0.2133
0.3780
0.5116
HCC1806
TNBC
Basal A
Nilotinib
ABL
nRTK
12239.145
uM
inf
inf
0.9597 0.9597 0.0000 0.0201
-0.0222
2.1348
MCF 10F
NM
-
PS-1145
IKK
NFKB
7486.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0198
-0.3050
1.1517
BT-20
TNBC
Basal A
Selumetinib
MEK
MAPK
11854.155
uM
inf
inf
0.9135 0.9135 0.0000 0.0714
0.3056
1.3396
MCF 10F
NM
-
FTase Inhibitor I
Ftase
MAPK
12254.154
uM
inf
inf
1.0500 1.0500 0.0000 -0.0451
-13.9008
1.6307
MDA-MB-157
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7882.016
uM
inf
inf
0.7087 0.7087 0.0000 0.1209
0.5649
1.0905
Hs 578T
TNBC
Basal B
Nutlin 3a
MDM2
MDM2
7472.066
uM
inf
inf
0.9265 0.9265 0.0000 -0.0306
0.0660
1.8363
MCF7
HR+
Luminal
Purvalanol A
CDK1
CDK
7493.067
uM
inf
inf
0.9222 0.9222 0.0000 0.0803
0.0000
1.3684
SUM159PT
TNBC
Basal B
ZM-447439
AURK
AURK
11057.15
uM
inf
0.43340
0.6315 0.6227 5.0000 0.1138
0.9875
4.0042
MCF 10F
NM
-
5-FU
TYMS
TYMS
7872.017
uM
inf
inf
1.0126 1.0126 0.0000 0.1656
0.1751
1.5155
HBL-100
Unknown
Unknown
Cisplatin
DNA cross-linker
DNA cross-linker
7807.017
uM
inf
inf
-0.4695 -0.4695 0.0000 0.2218
0.4545
2.2007
BT-474
HER2amp
Luminal
Gemcitabine
DNA replication
DNA replication
9163.011
uM
inf
0.03578
0.4237 0.5176 5.0000 0.3079
0.9295
0.6266
BT-20
TNBC
Basal A
PS-1145
IKK
NFKB
10385.065
uM
inf
inf
0.4664 0.4664 0.0000 0.3016
0.3040
0.6599
HCC70
TNBC
Basal A
Nilotinib
ABL
nRTK
12400.17
uM
inf
inf
1.0500 1.0500 0.0000 -0.0014
-0.0040
1.1992